Tacrine inhibits nicotinic secretory and current responses in adrenal chromaffin cells.

[1]  M. Reuben,et al.  Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum , 1994, British journal of pharmacology.

[2]  D. F. Story,et al.  PREJUNCTIONAL ACTIONS OF TACRINE ON AUTONOMIC NEUROEFFECTOR TRANSMISSION IN RABBIT ISOLATED PULMONARY ARTERY AND RAT ISOLATED ATRIA , 1992, Clinical and experimental pharmacology & physiology.

[3]  R. Gross,et al.  Tetrahydroaminoacridine (THA) reduces voltage-dependent calcium currents in rat sensory neurons , 1991, Neuroscience Letters.

[4]  A. Harvey,et al.  Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4‐diaminopyridine on skeletal neuromuscular transmission in vitro , 1991, British journal of pharmacology.

[5]  S. Tågerud,et al.  Tetrahydroaminoacridine (tacrine) stimulates neurosecretion at mammalian motor endplates , 1990, British journal of pharmacology.

[6]  I. Williams,et al.  Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes. , 1989, European journal of pharmacology.

[7]  D. Mash,et al.  Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. , 1989, The Journal of pharmacology and experimental therapeutics.

[8]  B. Winblad,et al.  Effects of THA on ionic currents in myelinated axons of Xenopus laevis. , 1989, European journal of pharmacology.

[9]  S. E. Freeman,et al.  Blockade of a cardiac K+ channel by tacrine: interactions with muscarinic and adenosine receptors. , 1988, European journal of pharmacology.

[10]  E. Perry,et al.  Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro , 1988, Neuroscience Letters.

[11]  C. Schauf,et al.  Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola. , 1987, The Journal of pharmacology and experimental therapeutics.

[12]  W. Osterrieder.  9‐Amino‐1,2,3,4‐tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels , 1987, British journal of pharmacology.

[13]  M. Rogawski.  Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. , 1987, European journal of pharmacology.

[14]  J. C. Lodder,et al.  9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current. , 1987, European journal of pharmacology.

[15]  C. Cotman,et al.  Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons , 1987, Neuroscience Letters.

[16]  A. Kling,et al.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. , 1986, The New England journal of medicine.

[17]  B. Livett,et al.  Biphasic Effect of Eserine and Other Acetylcholinesterase Inhibitors on the Nicotinic Response to Acetylcholine in Cultured Adrenal Chromaffin Cells , 1982, Journal of neurochemistry.

[18]  Y. Nakazato,et al.  THE EFFECT OF VERATRIDINE ON THE RELEASE OF CATECHOLAMINES FROM THE PERFUSED ADRENAL GLAND , 1979, British journal of pharmacology.

[19]  J. Hochman,et al.  Catecholamine secretion by isolated adrenal cells. , 1976, Biochimica et biophysica acta.

[20]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[21]  T. Tufte,et al.  Inhibition of Cholinesterases by Tetrahydroaminacrin. , 1961 .